Polianta LTD Novo Cure LTD Transaction History

Polianta LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 04, 2023	BUY	$56.44 - $118.81 $750,652 - $1.58 Million	13,300 New	13,300 $799,000
Q2 2020 Jul 09, 2020	SELL	$57.2 - $74.41 $743,600 - $967,330	-13,000 Closed	0 $0
Q1 2020 Apr 07, 2020	SELL	$57.05 - $95.75 $68,460 - $114,900	-1,200 Reduced 8.45%	13,000 $875,000
Q4 2019 Jan 13, 2020	BUY	$68.3 - $93.8 $129,770 - $178,220	1,900 Added 15.45%	14,200 $1.2 Million
Q3 2019 Oct 09, 2019	BUY	$61.86 - $97.8 $760,878 - $1.2 Million	12,300 New	12,300 $919,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

Stay updated on Polianta LTD with notifications on news.